G. Baltayiannis

发表

Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis

A. Fotopoulos, E. Tsianos, G. Kalambokis, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Scintigraphic evaluation of intrapulmonary shunt in normoxemic cirrhotic patients and effects of terlipressin

A. Fotopoulos, E. Tsianos, G. Kalambokis, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia

E. Tsianos, G. Baltayiannis, G. Kalambokis, 2010, Scandinavian journal of gastroenterology.

High von Willebrand factor antigen levels and procoagulant imbalance may be involved in both increasing severity of cirrhosis and portal vein thrombosis

L. Christou, G. Baltayiannis, G. Kalambokis, 2016, Hepatology.

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

G. Glantzounis, K. Katsanos, D. Christodoulou, 2019, BMC Gastroenterology.

Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis

M. Christaki, D. Christodoulou, I. Tsiakas, 2018, European journal of gastroenterology & hepatology.

Conversion of Propranolol to Carvedilol Improves Renal Perfusion and Outcome in Patients With Cirrhosis and Ascites

L. Michalis, H. Milionis, M. Christaki, 2020, Journal of clinical gastroenterology.

Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow

P. Karayiannis, G. Baltayiannis, 2014, Journal of viral hepatitis.

Propranolol use beyond 6 months increases mortality in patients with Child‐Pugh C cirrhosis and ascites

D. Christodoulou, L. Christou, G. Baltayiannis, 2016, Hepatology.

Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1.

D. Christodoulou, L. Christou, G. Baltayiannis, 2017, European journal of gastroenterology & hepatology.

Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C

H. Milionis, M. Elisaf, E. Tsianos, 2008, Journal of gastroenterology and hepatology.

The true value of serum elastase-1 in endoscopic retrograde cholangiopancreatography (ERCP).

K. Katsanos, D. Christodoulou, A. Katsaraki, 2002, European journal of internal medicine.

Pancreatitis Potentially Associated Drugs as a Risk Factor for Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Cohort Study

J. Ioannidis, A. Tatsioni, K. Katsanos, 2013, Pancreas.

von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.

D. Christodoulou, E. Tsianos, L. Christou, 2016, Journal of hepatology.

Systematic review: hepatic fibrosis – regression with therapy

C. Zois, E. Tsianos, P. Karayiannis, 2008, Alimentary pharmacology & therapeutics.

Thrombin generation measured as thrombin–antithrombin complexes predicts clinical outcomes in patients with cirrhosis

E. Tsianos, L. Christou, N. Kolaitis, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Steatosis and steatohepatitis in postmortem material from Northwestern Greece.

A. Goussia, C. Zois, E. Tsianos, 2010, World journal of gastroenterology.

High Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in ICU Patients: An Observational Study.

D. Christodoulou, A. Karakosta, G. Papathanakos, 2023, Journal of intensive care medicine.

Haemostatic balance in patients with end-stage cirrhosis: low protein C is the predominant coagulant protein deficiency.

D. Christodoulou, L. Christou, G. Baltayiannis, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Scintigraphic evaluation of intrapulmonary shunt in normoxemic cirrhotic patients and effects of terlipressin

A. Fotopoulos, E. Tsianos, S. Tsiouris, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis.

D. Christodoulou, G. Baltayiannis, G. Kalambokis, 2016, World journal of gastroenterology.

An overview of recent treatment options for primary sclerosing cholangitis

G. Baltayiannis, F. Fousekis, I. Mousavere, 2023, Annals of gastroenterology.

Red signs and not severity of cirrhosis should determine non-selective β-blocker treatment in Child–Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use

D. Christodoulou, L. Christou, G. Baltayiannis, 2016, Gut.